JMV2959
JMV2959
JMV2959 is a chemical compound that acts as a selective antagonist of the dopamine D3 receptor. It has been studied for its potential therapeutic applications in various neurological and psychiatric disorders, including Parkinson's disease and addiction.
Chemical Structure and Properties[edit | edit source]
JMV2959 is a small molecule with the following chemical structure:
- IUPAC Name: (2S)-N-[(1S)-1-(3,4-dichlorophenyl)ethyl]-2-(pyrrolidin-1-ylmethyl)pyrrolidine-1-carboxamide
- Molecular Formula: C18H24Cl2N4O
- Molecular Weight: 383.32 g/mol
The compound is characterized by its pyrrolidine and dichlorophenyl groups, which contribute to its binding affinity and selectivity for the dopamine D3 receptor.
Pharmacology[edit | edit source]
JMV2959 is known for its high affinity and selectivity for the dopamine D3 receptor, a subtype of dopamine receptor that is primarily expressed in the limbic areas of the brain. This receptor is implicated in the regulation of mood, reward, and addiction.
Mechanism of Action[edit | edit source]
As a D3 receptor antagonist, JMV2959 binds to the receptor and inhibits its activity. This action can modulate dopaminergic signaling in the brain, potentially reducing the reinforcing effects of addictive substances and alleviating symptoms of disorders like Parkinson's disease.
Therapeutic Potential[edit | edit source]
Research has suggested that JMV2959 may have therapeutic potential in the following areas:
- Addiction: By blocking D3 receptors, JMV2959 may reduce the rewarding effects of drugs such as cocaine and alcohol, thereby aiding in addiction treatment.
- Parkinson's Disease: The compound may help manage symptoms by modulating dopaminergic pathways that are disrupted in Parkinson's disease.
Research and Development[edit | edit source]
JMV2959 has been the subject of various preclinical studies. These studies have demonstrated its efficacy in animal models of addiction and Parkinson's disease, but further research is needed to evaluate its safety and effectiveness in humans.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
